← Back to Search

Immunomodulator

Abatacept for Interstitial Lung Disease (ATtackMy-ILD Trial)

Phase 2
Waitlist Available
Research Sponsored by Rohit Aggarwal, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Summary

This trial is testing whether a drug called Abatacept can treat interstitial lung disease associated with the anti-synthetase syndrome.

Eligible Conditions
  • Interstitial Lung Disease
  • Myositis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Vital capacity
Secondary outcome measures
Dyspnea
Time to improvement in FVC% by ≥10
Time to progression free survival where progression

Side effects data

From 2023 Phase 3 trial • 613 Patients • NCT03086343
9%
UPPER RESPIRATORY TRACT INFECTION
7%
NASOPHARYNGITIS
7%
URINARY TRACT INFECTION
5%
HYPERTENSION
100%
80%
60%
40%
20%
0%
Study treatment Arm
Upadacitinib 15 mg
Abatacept

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AbataceptExperimental Treatment1 Intervention
Subcutaneous injection of abatacept 125 mg weekly for 24 weeks. 24 week optional follow up phase all subjects receive abatacept 125 mg weekly.
Group II: PlaceboPlacebo Group1 Intervention
Subcutaneous placebo injection weekly for 24 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Abatacept
2005
Completed Phase 4
~112160

Find a Location

Who is running the clinical trial?

Rohit Aggarwal, MDLead Sponsor
2 Previous Clinical Trials
146 Total Patients Enrolled
Bristol-Myers SquibbIndustry Sponsor
2,652 Previous Clinical Trials
4,130,729 Total Patients Enrolled
~2 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top